Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma

BACKGROUND: The immunotherapy with immune checkpoints inhibitors (ICI) has changed the life expectancy in metastatic melanoma (MM) patients. Nevertheless, several patients do not respond hence, the identification and validation of novel biomarkers of response to ICI is of crucial importance. Circula...

Descripción completa

Detalles Bibliográficos
Autores principales: Serratì, Simona, Guida, Michele, Di Fonte, Roberta, De Summa, Simona, Strippoli, Sabino, Iacobazzi, Rosa Maria, Quarta, Alessandra, De Risi, Ivana, Guida, Gabriella, Paradiso, Angelo, Porcelli, Letizia, Azzariti, Amalia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764806/
https://www.ncbi.nlm.nih.gov/pubmed/35042524
http://dx.doi.org/10.1186/s12943-021-01490-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764806/
https://www.ncbi.nlm.nih.gov/pubmed/35042524
http://dx.doi.org/10.1186/s12943-021-01490-9

Ejemplares similares